SER Stock Analysis: Buy, Sell, or Hold?
SER - Serina Therapeutics, Inc.
$3.25
-0.29 (-8.19%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When SER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: SER is 9.4% above fair value ($2.97). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: SER is 9.4% above fair value ($2.97). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: SER is currently trading at $3.25, which is considered extended relative to its 30-day fair value range of $2.22 to $2.97.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $2.51, while resistance sits at $4.08. Short-term momentum is weak, with the stock down 8.2% recently.
Market Sentiment: SER has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+267.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $2.51, while resistance sits at $4.08. Short-term momentum is weak, with the stock down 8.2% recently.
Market Sentiment: SER has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+267.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$2.22 -
$2.97
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
Protect Your Profits
Holding SER? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.4% above fair value)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-8.2%)
- BULLISH: Trading 267.2% below Wall St target ($13.00)
Fair Price Analysis
30-Day Fair Range
$2.22 -
$2.97
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.51
Resistance Level
$4.08
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.96
Wall Street Target
$13.00
(+267.2%)
Revenue Growth (YoY)
154.9%
Earnings Growth (YoY)
-43.5%
Last updated: January 30, 2026 4:02 PM ET
Data refreshes hourly during market hours. Next update: 5:02 PM
Data refreshes hourly during market hours. Next update: 5:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SER showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |
Advanced SER Option Strategies
Professional options setups generated by AI based on today's SER price and gamma walls.
